Table 4 Prevalence of myocardial infarction in NHANES participants (%)^a

 35–39

0.19 (0.31)

1.11 (0.74)

0.33 (0.43)

0 (0)

0.42 (0.4)

0.41 (0.4)

0.45 (0.44)

 40–44

2.72 (1.13)

2.41 (0.99)

1.32 (0.79)

0.19 (0.3)

0.61 (0.52)

2.03 (0.88)

1.66 (0.86)

 45–49

4.78 (1.72)

0.24 (0.33)

1.78 (0.98)

4.48 (1.45)

2.67 (1.07)

0.25 (0.31)

1.17 (0.75)

 50–54

3.37 (1.42)

3.81 (1.31)

5.49 (1.73)

1.81 (0.96)

1.99 (0.84)

5.84 (1.43)

2.46 (1.02)

 55–59

15.21 (3.26)

8.77 (2.37)

9.00 (2.63)

4.57 (1.82)

5.91 (1.72)

8.68 (1.86)

4.48 (1.46)

 60–64

15.16 (2.43)

8.25 (1.97)

9.55 (2.13)

10.4 (2.23)

7.47 (1.54)

8.81 (1.76)

7.16 (1.58)

 65–69

8.78 (2.06)

14.76 (2.8)

18.25 (2.86)

15.42 (2.85)

14.61 (2.52)

10.29 (2.06)

11.33 (2.30)

 70–74

14.72 (2.72)

10.20 (2.29)

19.45 (2.93)

11.20 (2.58)

13.23 (2.52)

14.22 (2.55)

16.70 (3.10)

 75–79

16.46 (3.24)

18.81 (3.51)

11.82 (2.7)

21.68 (3.89)

16.75 (2.88)

16.89 (3.16)

10.38 (2.87)

 80+

17.47 (2.78)

20.83 (2.67)

21.99 (2.8)

22.73 (3.06)

22.34 (2.98)

17.29 (2.67)

14.93 (2.77)

 35–39

0 (0)

0.36 (0.38)

0 (0)

0 (0)

0.79 (0.55)

0.47 (0.41)

0 (0)

 40–44

0.08 (0.2)

0.73 (0.55)

0.41 (0.44)

1.89 (0.91)

0.78 (0.56)

1.74 (0.75)

1.53 (0.79)

 45–49

0.63 (0.57)

0.14 (0.25)

2.79 (1.2)

0.88 (0.66)

1.80 (0.84)

1.87 (0.8)

0.54 (0.49)

 50–54

1.36 (0.86)

2.01 (1.02)

3.19 (1.29)

3.52 (1.37)

2.35 (0.98)

1.9 (0.85)

0.90 (0.58)

 55–59

1.18 (0.99)

2.90 (1.41)

4.57 (1.85)

1.93 (1.18)

1.89 (0.94)

1.54 (0.88)

4.34 (1.42)

 60–64

3.79 (1.28)

5.97 (1.63)

4.57 (1.43)

4.24 (1.46)

3.93 (1.12)

3.16 (1.03)

2.70 (0.98)

 65–69

6.28 (1.78)

4.39 (1.58)

6.50 (1.83)

5.87 (1.95)

3.94 (1.37)

1.79 (0.96)

5.73 (1.76)

 70–74

4.71 (1.65)

8.31 (2.18)

8.15 (2.21)

6.78 (2.18)

8.16 (1.91)

2.51 (1.07)

11.13 (2.53)

 75–79

7.65 (2.39)

13.50 (3.03)

11.38 (2.81)

7.53 (2.78)

5.39 (1.80)

1.84 (1.14)

4.55 (2.05)

 80+

9.92 (1.95)

11.44 (1.81)

12.63 (1.93)

11.29 (2.21)

12.45 (2.13)

8.54 (1.88)

11.20 (2.26)